Patents by Inventor Bijay Kumar Padhi

Bijay Kumar Padhi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20240016732
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: January 27, 2023
    Publication date: January 18, 2024
    Applicant: Scilex Holding Company
    Inventors: Sagar Munjal, Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Methods for treating inflammatory skin conditions
    Publication number: 20230131030
    Abstract: The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
    Type: Application
    Filed: June 20, 2022
    Publication date: April 27, 2023
    Inventors: Swati KULKARNI, Bijay Kumar PADHI, Shanvas ALIKUNJU, Rajeev Singh RAGHUVANSHI, Srinivas Ramchandra SIDGIDDI, Anirudh GAUTAM
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20220241298
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: September 10, 2021
    Publication date: August 4, 2022
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Methods for treating inflammatory skin conditions
    Patent number: 11364212
    Abstract: The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: June 21, 2022
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Swati Kulkarni, Bijay Kumar Padhi, Shanvas Alikunju, Rajeev Singh Raghuvanshi, Srinivas Ramchandra Sidgiddi, Anirudh Gautam
  • MODIFIED RELEASE DOXYCYCLINE COMPOSITION
    Publication number: 20220031714
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: February 19, 2021
    Publication date: February 3, 2022
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Methods for treating inflammatory skin conditions
    Patent number: 11191740
    Abstract: The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: December 7, 2021
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Swati Kulkarni, Bijay Kumar Padhi, Shanvas Alikunju, Rajeev Singh Raghuvanshi, Srinivas Ramchandra Sidgiddi, Anirudh Gautam
  • PHARMACEUTICAL COMPOSITIONS FOR MINOCYCLINE
    Publication number: 20210353649
    Abstract: The present application relates to a method of orally administering once daily tablet of minocycline to a subject in need thereof, wherein said tablet is substantially free of lactose. The present application also relates to processes for preparing said once daily tablet of minocycline that provides reduced stock keeping units with improved inventory by supplying multiple doses of minocycline in single tablet.
    Type: Application
    Filed: July 29, 2021
    Publication date: November 18, 2021
    Inventors: Rohit LOWALEKAR, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Pharmaceutical compositions for minocycline
    Patent number: 11103517
    Abstract: The present application relates to a method of orally administering once daily tablet of minocycline to a subject in need thereof, wherein said tablet is substantially free of lactose. The present application also relates to processes for preparing said once daily tablet of minocycline that provides reduced stock keeping units with improved inventory by supplying multiple doses of minocycline in single tablet.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: August 31, 2021
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Rohit Lowalekar, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • Bioequivalent pharmaceutical composition of vortioxetine hydrobromide
    Patent number: 11020390
    Abstract: The invention relates to vortioxetine hydrobromide having particle size distribution of D98 100-200?, D50 35-90? and D5 7-30? as well as to a stable, reproducible and bioequivalent pharmaceutical composition comprising vortioxetine hydrobromide having particle size distribution of D98 100-200?, D50 35-90? and D5 7-30? and one or more pharmaceutically acceptable excipient. It is produced by wet granulation techniques.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: June 1, 2021
    Assignee: UNICHEM LABORATORIES LTD
    Inventors: Dhananjay Sathe, Bijay Kumar Padhi, Pravin Kumar Maurya
  • Methods for treating inflammatory skin conditions
    Publication number: 20210121420
    Abstract: The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 29, 2021
    Applicant: DR. REDDY'S LABORATORIES LTD.
    Inventors: Swati KULKARNI, Bijay Kumar PADHI, Shanvas ALIKUNJU, Rajeev Singh RAGHUVANSHI, Srinivas Ramchandra SIDGIDDI, Anirudh GAUTAM
  • Modified release doxycycline composition
    Patent number: 10953022
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: March 23, 2021
    Assignee: GALDERMA HOLDING SA
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • Methods for treating inflammatory skin conditions
    Patent number: 10905664
    Abstract: The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: February 2, 2021
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Swati Kulkarni, Bijay Kumar Padhi, Shanvas Alikunju, Rajeev Singh Raghuvanshi, Srinivas Ramchandra Sidgiddi, Anirudh Gautam
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20200352853
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 12, 2020
    Inventors: Sagar MUNJAL, Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Oral composition of celecoxib for treatment of pain
    Patent number: 10799517
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: October 13, 2020
    Assignee: DR. REDDY'S LABORATORIES LTD
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Oral composition of celecoxib for treatment of pain
    Patent number: 10722456
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: July 28, 2020
    Assignee: DR. REDDY'S LABORATORIES LTD
    Inventors: Sagar Munjal, Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • METHODS FOR TREATING INFLAMMATORY SKIN CONDITIONS
    Publication number: 20200222345
    Abstract: The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
    Type: Application
    Filed: March 23, 2020
    Publication date: July 16, 2020
    Applicant: DR. REDDY'S LABORATORIES LTD.
    Inventors: Swati KULKARNI, Bijay Kumar PADHI, Shanvas ALIKUNJU, Rajeev Singh RAGHUVANSHI, Srinivas Ramchandra SIDGIDDI, Anirudh GAUTAM
  • BIOEQUIVALENT PHARMACEUTICAL COMPOSITION OF VORTIOXETINE HYDROBROMIDE
    Publication number: 20200188391
    Abstract: The invention relates to vortioxetine hydrobromide having particle size distribution of D98 100-200?, D50 35-90? and D5 7-30? as well as to a stable, reproducible and bioequivalent pharmaceutical composition comprising vortioxetine hydrobromide having particle size distribution of D98 100-200?, D50 35-90? and D5 7-30? and one or more pharmaceutically acceptable excipient. It is produced by wet granulation techniques.
    Type: Application
    Filed: February 15, 2018
    Publication date: June 18, 2020
    Inventors: Dhananjay Sathe, Bijay Kumar Padhi, Pravin Kumar Maurya
  • PHARMACEUTICAL COMPOSITIONS FOR TREATING ACNE
    Publication number: 20200085775
    Abstract: The present application relates to pharmaceutical compositions comprising retinoic acid or its derivatives such as isotretinoin and processes for preparing thereof. It also provides methods for treating acne by administering such pharmaceutical composition to a patient in need thereof.
    Type: Application
    Filed: November 21, 2019
    Publication date: March 19, 2020
    Inventors: Yogesh Bapurao PAWAR, Kailas KHOMANE, Saurabh SRIVASTAVA, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • MODIFIED RELEASE DOXYCYCLINE COMPOSITION
    Publication number: 20200078378
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 12, 2020
    Applicant: Nestle Skin Health SA
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Pharmaceutical compositions for treating acne
    Patent number: 10517846
    Abstract: The present application relates to pharmaceutical compositions comprising retinoic acid or its derivatives such as isotretinoin and processes for preparing thereof. It also provides methods for treating acne by administering such pharmaceutical composition to a patient in need thereof.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: December 31, 2019
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Yogesh Bapurao Pawar, Kailas Khomane, Saurabh Srivastava, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi